Claro Advisors LLC purchased a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the fourth quarter, ...
Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...
Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...
The Company presentation and Q&A session will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on ONWARD Medical’s ...
Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty ...